/People

Mark Kornfeld

CEO at Melius Pharma

Stockholm, Stockholm County, Sweden

Find your path to Mark

141 people in our graph share verified history with Mark — schools, employers, funds. One of them is your warm intro.

CEO at Melius Pharma

Intro paths

→

In turn, Mark can intro founders to Melius Pharma's investors below.

Melius Pharma's investors · 1

Experience

  1. Aeriant TherapeuticsBoard Membercurrent2025 — present
  2. Melius PharmaCEOcurrent2021 — present
  3. Mark Kornfeld ConsultingIndependent Pricing & Market Access Consultant2017 — 2021Paris Area, France
  4. Creativ-CeuticalDirector, Pricing & Market Access2015 — 2017Paris Area, France
  5. OptumInsightAssociate Director2013 — 2014Paris
  6. Valena Health ABOwner2011 — 2013
  7. Airsonett ABDirector Market Access and Sales2010 — 2011Ängelholm, Sweden
  8. Creativ-Ceutical (formerly Altipharm)Market Access Consultant2004 — 2009Paris, France
  9. OTL PharmaLicensing Manager2001 — 2004Paris, France
  10. Orphan EuropeLicensing Manager1999 — 2001Paris, France
  11. Bridgehead technologies LtdConsultant1999Leicestershire, UK
  12. Lundbeck SAHealth Economic Editor1998Paris, France

Skills & more

Orphan Drugs4Market Access12Market Research7Pharmaceutical Industry12Pharmaceutics6Market Analysis5Strategy5Medical Devices3Biotechnology10Business Development3Clinical Development1Oncology3
+4 moreClinical TrialsStart-upsLife SciencesManagement

From Mark's professional profile.

Frequently asked questions

Who is Mark Kornfeld?
CEO at Melius Pharma
Where does Mark Kornfeld work?
Mark Kornfeld is CEO at Melius Pharma.
Where did Mark Kornfeld go to school?
Mark Kornfeld studied at Lund University (PhD, Physiology); EMAUD; University of Lyon, France (European Market Access University Diploma, Market Access); Faculty of Medicine, University of Regensburg, Germany (Post Doc, Molecular Biology).

Founder mafias

Same school

Shared employers